Yiming (Beijing) Cell Biotechnology Co., Ltd. announced that it has raised $30 million in funding led by Goldstone Investment Group Limited and CLSA Capital Partners on September 27, 2022. THe transaction also includes participation from BGI Co-Win, Wenzhou Capital, Finnova Capital, IDG Capital Partners Co., Ltd. and Xingtou Capital, and existing investor Beijing FOF Capital Co.,Ltd., Huagai Capital Co., Ltd.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.024 HKD | -4.00% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 6.64M | |
-6.03% | 113B | |
-3.98% | 87.91B | |
+20.96% | 63.76B | |
+5.29% | 61.9B | |
+10.12% | 42.86B | |
+7.95% | 40.84B | |
+18.92% | 34.58B | |
+5.88% | 25.48B | |
-5.25% | 22.13B |
- Stock Market
- Equities
- 901 Stock
- News Goldstone Investment Group Limited
- Yiming Cell Biotechnology Co., Ltd. announced that it has received $30 million in funding from a group of investors